hClpP activator D9 is primarily used in scientific research to study the mechanisms of the hClpP enzyme, which is involved in protein quality control within cells, particularly in bacteria. This research aids in the development of new, highly effective antimicrobial drugs, as hClpP is a key target for inhibiting bacterial growth. Additionally, studies are exploring the use of hClpP activator D9 in therapies for diseases related to protein abnormalities in human cells, potentially leading to treatments for genetic disorders and neurological conditions in the future.